Tonix Pharmaceuticals’ Acquisition of Preclinical Infectious Disease Portfolio from Healion Bio

Laura Testa
Tagged:

Lowenstein represented Tonix Pharmaceuticals Holding Corp. in the transaction.Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) signed an agreement to acquire assets of Healion Bio, Inc., including its entire…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here